WHITEHAWK THERAPEUTICS, INC. (WHWK) Operating margin 2018–2025
WHITEHAWK THERAPEUTICS, INC. (WHWK) operating margin by fiscal year — reported operating income divided by reported revenue.
-1601.1%FY2025 · since FY2018: -55.5% → -1601.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1601.1% | -1341.5 pp |
| FY2024 | -259.6% | +35.7 pp |
| FY2023 | -295.4% | +116.6 pp |
| FY2022 | -411.9% | +382.5 pp |
| FY2021 | -794.4% | -776.2 pp |
| FY2020 | -18.2% | — |
| FY2018 | -55.5% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More WHWK financial trends
WHWK RevenueWHWK Net incomeWHWK Net marginWHWK Gross profitWHWK Gross marginWHWK Operating incomeWHWK Operating cash flowWHWK Free cash flowWHWK Capital expendituresWHWK Return on equityWHWK Stock buybacksWHWK Dividends paidWHWK Total assetsWHWK Total liabilitiesWHWK Shareholders’ equityWHWK overview →